PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global cell line development market by product type • Global cell line development market by media and reagents • Global cell line development market by equipment PART 07: Geographical segmentation • Global cell line development market by geography • Cell line development market in Americas • Cell line development market in EMEA • Cell line development market in APAC PART 08: Decision framework PART 09: Drivers and challenges • Market drivers • Market challenges PART 10: Market trends • Increase demand for regenerative medicine • Adoption of laboratory automation • Growing prevalence of autoimmune diseases and cancer PART 11: Vendor landscape • Competitive scenario • Investment opportunity PART 12: Key vendor analysis • GE Healthcare • Lonza • Merck Millipore • Thermo Fisher Scientific • Other prominent vendors PART 13: Appendix • List of abbreviations List of Exhibits Exhibit 01: Procedure of cell line development Exhibit 02: Global cell line development market: Market overview Exhibit 03: Global cell line development market 2016-2021 ($ billions) Exhibit 04: Global cell line development by source Exhibit 05: Global cell line development by application 2016 Exhibit 06: Factors impacting global cell line development market Exhibit 07: Five forces analysis Exhibit 08: Global cell line development market by product type 2016-2021 (% share) Exhibit 09: Global cell line development market by product type: Snapshot Exhibit 10: Global cell line development market by media and reagents 2016-2021 ($ billions) Exhibit 11: Global cell line development market by equipment 2016-2021 ($ billions) Exhibit 12: Global cell line development market by geography 2016-2021 (% share) Exhibit 13: Global cell line development market by geography: Snapshot Exhibit 14: Cell line development market in Americas: Overview Exhibit 15: Cell line development market in Americas 2016-2021 ($ billions) Exhibit 16: Cell line development market in EMEA: Overview Exhibit 17: Cell line development market in EMEA 2016-2021 ($ billions) Exhibit 18: Impact of BREXIT on the laboratory equipment market Exhibit 19: Cell line development market in APAC: Overview Exhibit 20: Cell line development market in APAC 2016-2021 ($ billions) Exhibit 21: Some therapeutic applications of mAbs Exhibit 22: Vaccine production from cell line development Exhibit 23: Disadvantages of cell line development Exhibit 24: Strategic success factors for vendors Exhibit 25: Competitive parameters in global cell line development market Exhibit 26: Investment opportunity mapping Exhibit 27: GE Healthcare: Profile Exhibit 28: GE Healthcare: Strength analysis Exhibit 29: GE Healthcare: Strategy assessment Exhibit 30: GE Healthcare: Opportunity assessment Exhibit 31: Lonza: Profile Exhibit 32: Lonza: Strength analysis Exhibit 33: Lonza: Strategy assessment Exhibit 34: Lonza: Opportunity assessment Exhibit 35: Merck Millipore: Strength analysis Exhibit 36: Merck Millipore: Strategy assessment Exhibit 37: Merck Millipore: Opportunity assessment Exhibit 38: Thermo Fisher Scientific: Profile Exhibit 39: Thermo Fisher Scientific: Strength analysis Exhibit 40: Thermo Fisher Scientific: Strategy assessment Exhibit 41: Thermo Fisher Scientific: Opportunity assessment Global Cryoablation Devices Market 2017-2021 PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Market overview • Cryoablation systems • Catheters and accessories PART 07: Market segmentation by end-user • Market overview • Hospitals and specialty clinics • ASCs PART 08: Geographical segmentation • Market overview • Cryoablation devices market in Americas • Cryoablation devices market in EMEA • Cryoablation devices market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Market growth through M&A • Paradigm shift toward minimally invasive procedures • Developing countries to emerge as growth engines for cryoablation devices market PART 12: Vendor landscape • Competitive landscape PART 13: Key vendor analysis • Medtronic • Galil Medical • CooperSurgical • Other prominent vendors PART 14: Appendix • List of abbreviations Exhibit 01: Market flow of global cryoablation devices in 2016 Exhibit 02: Overview of global cryoablation devices market 2016 Exhibit 03: Global cryoablation devices market 2016-2021 ($ millions) Exhibit 04: Five forces analysis Exhibit 05: Global cryoablation devices market by product Exhibit 06: Global cryoablation systems: Market overview Exhibit 07: Global cryoablation systems market 2016-2021 ($ millions) Exhibit 08: Global cryoablation catheters and accessories: Market overview Exhibit 09: Global cryoablation catheters and accessories market 2016-2021 ($ millions) Exhibit 10: Global cryoablation devices market by end-users 2016 Exhibit 11: Strategic analysis of global cryoablation devices market by end-users 2016 Exhibit 12: Buying criteria analysis: Global cryoablation devices market 2016 Exhibit 13: Global cryoablation devices market by geographical segmentation 2016 ($ millions) Exhibit 14: Cryoablation devices market in Americas 2016-2021 ($ millions) Exhibit 15: Cryoablation devices market in EMEA 2016-2021 ($ millions) Exhibit 16: Cryoablation devices market in APAC 2016-2021 ($ millions) Exhibit 17: Cost comparison of AF treatment by RF ablation and cryoablation procedures Exhibit 18: Product recalls due to regulatory aspects Exhibit 19: Percentage of cancer deaths among men and women in OECD member countries 2013 Exhibit 20: Competitive structure analysis of global cryoablation devices market 2016 Exhibit 21: Market penetration of vendors in global cryoablation devices market 2016 Exhibit 22: Strategic success factors of companies in global cryoablation devices market 2016 Exhibit 23: Medtronic: Key highlights Exhibit 24: Medtronic: Strength assessment Exhibit 25: Medtronic: Strategy assessment Exhibit 26: Medtronic: Opportunity assessment Exhibit 27: Galil Medical: Key highlights Exhibit 28: Galil Medical: Strength assessment Exhibit 29: Galil Medical: Strategy assessment Exhibit 30: Galil Medical: Opportunity assessment Exhibit 31: CooperSurgical: Key highlights Exhibit 32: CooperSurgical: Strength assessment Exhibit 33: CooperSurgical: Strategy assessment Exhibit 34: CooperSurgical: Opportunity assessment

GE Healthcare, Lonza, Merck Millipore, Thermo Fisher Scientific, Cobra Biologics, Corning, Molecular Devices, sartorious, SELEXIS, and WuXi Biologics.